Type 2 Inflammation

Podcast: Type 2 Inflammation: Health Disparities & Impact on Minority Populations
Illinois State Senator Mattie Hunter, Midwestern Regional Director, WIG Board of Directors
Dr. Debra Sierka, PharmD., Head of Dermatology, US Medical Affairs, Sanofi Genzyme
Dr. Gary Puckrein, PhD., President, National Minority Quality Forum (NMQF)
Kenny Mendez, CEO and President, the Asthma and Allergy Foundation of America (AAFA)
Type 2 Inflammation Resources: 

Podcast: It Take 2: Type 2 Inflammation (2020)

California State Senator Melissa Hurtado
Carole Huntsman, Head, Sanofi Genzyme North America and US Country Lead
Dr. Mandeep Kaur, Vice President, Head, North America Medical for Dupixent at Sanofi Genzyme
Dr. Tyra Bryant-Stephens, Director and Founder, The Community Asthma Prevention Program, Clinical Professor of Pediatrics, The Children’s Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania
People of all ages, genders, and backgrounds are connected by similar challenges because of one lesser known chronic condition known as Type 2 Inflammation. Recent scientific developments have shown that this overactive immune system response, underlies different atopic, allergic and inflammatory diseases. What exactly does that mean and how does it affect our families and communities? On this episode of the Women In Government Podcast, our panel discusses how the Type 2 Inflammation connection can help patients work with their doctors to gain control of their chronic disease.
As for policymakers and industry leaders, these chronic conditions impact communities of color and those in underserved communities. Now’s the time to get to work and support measures to address Type 2 Inflammation.

Webinar: It Takes Two - Type 2 Inflammation 

Type 2 Inflammation Resources: